MedPath

Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Not Applicable
Completed
Conditions
Hepatocellular Carcinoma Non-resectable
Interventions
Device: UNI-DEB
Registration Number
NCT03533920
Lead Sponsor
Jeil Pharmaceutical Co., Ltd.
Brief Summary

Pivotal Clinical Trial to Evaluate the Efficacy and Safety of UNI-DEB for Unresectable Hepatocellular Carcinoma

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
62
Inclusion Criteria
  • Over 19 years
  • Diagnosis of HCC
  • Unresectable asymtomatic uninodular or multinodular tumor.
  • Subject who maintain clinically normal hepatopetal flow without main portal vein closure
  • At least one measurable target lesion by CT or MRI which 10 mm or more and 100 mm or less.
  • ECOG Performance Status of 0 or 1.
  • Child-Pugh class A or B
  • Life expectancy of at least 6 months.
Exclusion Criteria
  • Another primary tumour, with the exception of conventional basal cell carcinoma or superficial bladder neoplasia
  • Hepatic resection, liver transplantation or Percutaneous local treatment
  • Previously received HCC related medical procedure
  • Previously treated with anthracyclines
  • Only measurable disease is within an area of the liver previously subjected to radiotherapy.
  • Child Pugh C
  • Active gastrointestinal bleeding within 6 months from screening.
  • Total bilirubin > 3mg/dL
  • WBC < 3,000cells/mm3
  • Platelet < 50,000mm3
  • Serum creatinine > 2mg/dL
  • INR> 1.4
  • ALT and AST > 5 times UNL
  • Diffuse HCC defined as >50% tumour involvement of the whole liver.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
UNI-DEBUNI-DEB-
Primary Outcome Measures
NameTimeMethod
Objective Response Rate by independent evaluator4 weeks after treatment
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (8)

Seoul National University Bundang Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

The Catholic University of Korea, Uijeongbu ST. Mary's Hospital

🇰🇷

Gyeonggi-do, Korea, Republic of

Inha University Hospital

🇰🇷

Incheon, Korea, Republic of

Pusan National University Hospital

🇰🇷

Pusan, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Severance Hospital

🇰🇷

Seoul, Korea, Republic of

Chonnam National University Hospital

🇰🇷

Gwangju, Korea, Republic of

The Catholic University of Korea, Seoul ST. Mary's Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath